AMARYLLIS (Q3989669): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Fix Beneficiary from Netherlands) |
(Changed an Item: Fix Beneficiary from Netherlands) |
||
| Property / beneficiary name (string) | |||
Neuroplast BV | |||
| Property / beneficiary name (string): Neuroplast BV / rank | |||
Normal rank | |||
| Property / beneficiary | |||
| Property / beneficiary: Q3987747 / rank | |||
Normal rank | |||
Revision as of 09:47, 16 December 2021
Project Q3989669 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMARYLLIS |
Project Q3989669 in Netherlands |
Statements
514,551.96 Euro
0 references
1,475,299.17 Euro
0 references
34.878 percent
0 references
1 June 2015
0 references
31 December 2017
0 references
Maastricht Instruments BV
0 references
Neuroplast BV
0 references
50°50'15.07"N, 5°42'29.66"E
0 references
50°49'57.32"N, 5°42'54.00"E
0 references
6200 MD
0 references
6229 EV
0 references
6229 EG
0 references
6200 MD
0 references
Een laagdrempelig platform voor de productie van een veilig, laagimmunogeen stamcel preparaat. (Dutch)
0 references
A low-threshold platform for the production of a safe, low-immune stem cell preparation. (English)
15 December 2021
0 references
Une plate-forme à seuil bas pour la production d’une préparation sûre de cellules souches à faible taux d’immune. (French)
15 December 2021
0 references
Eine niedrigschwellige Plattform für die Herstellung einer sicheren, niedrigimmunen Stammzellpräparation. (German)
15 December 2021
0 references
Identifiers
OP-2014-2023-Zuid-PROJ-00009
0 references